These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11728193)

  • 1. Synthesis and biological studies of novel nucleoside phosphoramidate prodrugs.
    Tobias SC; Borch RF
    J Med Chem; 2001 Dec; 44(25):4475-80. PubMed ID: 11728193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of novel 5-fluoro-2'-deoxyuridine phosphoramidate prodrugs.
    Freel Meyers CL; Hong L; Joswig C; Borch RF
    J Med Chem; 2000 Nov; 43(22):4313-8. PubMed ID: 11063625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfonyl-containing nucleoside phosphotriesters and phosphoramidates as novel anticancer prodrugs of 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP).
    Sun YW; Chen KM; Kwon CH
    Mol Pharm; 2006; 3(2):161-73. PubMed ID: 16579645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of a cytarabine phosphoramidate prodrug.
    Tobias SC; Borch RF
    Mol Pharm; 2004; 1(2):112-6. PubMed ID: 15832507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antitumor evaluation of bis[(pivaloyloxy)methyl] 2'-deoxy-5-fluorouridine 5'-monophosphate (FdUMP): a strategy to introduce nucleotides into cells.
    Farquhar D; Khan S; Srivastva DN; Saunders PP
    J Med Chem; 1994 Nov; 37(23):3902-9. PubMed ID: 7966151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs.
    Wu W; Borch RF
    Mol Pharm; 2006; 3(4):451-6. PubMed ID: 16889439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 5-fluoro-2'-deoxyuridine phosphoramidate analogs.
    Fries KM; Joswig C; Borch RF
    J Med Chem; 1995 Jul; 38(14):2672-80. PubMed ID: 7629806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2'-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes.
    Vande Voorde J; Liekens S; McGuigan C; Murziani PG; Slusarczyk M; Balzarini J
    Biochem Pharmacol; 2011 Sep; 82(5):441-52. PubMed ID: 21658373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anticancer activities of amphiphilic 5-fluoro-2'-deoxyuridylic acid prodrugs.
    Ludwig PS; Schwendener RA; Schott H
    Eur J Med Chem; 2005 May; 40(5):494-504. PubMed ID: 15893023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of aromatic amino acid phosphoramidates of 5-fluoro-2'-deoxyuridine and 1-beta-arabinofuranosylcytosine: evidence of phosphoramidase activity.
    Abraham TW; Kalman TI; McIntee EJ; Wagner CR
    J Med Chem; 1996 Nov; 39(23):4569-75. PubMed ID: 8917645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and interactions with thymidylate synthase of 2,4-dithio analogues of dUMP and 5-fluoro-dUMP.
    Dzik JM; Bretner M; Kulikowski T; Gołos B; Jarmuła A; Poznański J; Rode W; Shugar D
    Biochim Biophys Acta; 1996 Mar; 1293(1):1-8. PubMed ID: 8652614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5'-[4-(Pivaloyloxy)-1,3,2-dioxaphosphorinan-2-yl]-2'-deoxy-5-fluorouridine: a membrane-permeating prodrug of 5-fluoro-2'-deoxyuridylic acid (FdUMP).
    Farquhar D; Chen R; Khan S
    J Med Chem; 1995 Feb; 38(3):488-95. PubMed ID: 7853342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclic analogues of 5-fluoro-dUMP and 5-fluoro-2'-deoxyuridine: synthesis and inhibition of thymidylate synthase and tumour cell growth.
    Felczak K; Gołos B; Dzik JM; Rode W; Bretner M; Shugar D; Kulikowski T
    Acta Biochim Pol; 1998; 45(1):75-82. PubMed ID: 9701498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibition.
    Bijnsdorp IV; Comijn EM; Padron JM; Gmeiner WH; Peters GJ
    Oncol Rep; 2007 Jul; 18(1):287-91. PubMed ID: 17549381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity and in-vivo tolerance of FdUMP[10]: a novel pro-drug of the TS inhibitory nucleotide FdUMP.
    Gmeiner WH; Skradis A; Pon RT; Liu J
    Nucleosides Nucleotides; 1999; 18(6-7):1729-30. PubMed ID: 10474257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular delivery of nucleoside diphosphates: a prodrug approach.
    Kang SH; Sinhababu AK; Cory JG; Mitchell BS; Thakker DR; Cho MJ
    Pharm Res; 1997 Jun; 14(6):706-12. PubMed ID: 9210185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing a pronucleotide stratagem: lessons from amino acid phosphoramidates of anticancer and antiviral pyrimidines.
    Drontle DP; Wagner CR
    Mini Rev Med Chem; 2004 May; 4(4):409-19. PubMed ID: 15134543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Substituted N(4)-hydroxy-2'-deoxycytidines and their 5'-monophosphates: synthesis, conformation, interaction with tumor thymidylate synthase, and in vitro antitumor activity.
    Felczak K; Miazga A; Poznański J; Bretner M; Kulikowski T; Dzik JM; Gołos B; Zieliński Z; Cieśla J; Rode W
    J Med Chem; 2000 Nov; 43(24):4647-56. PubMed ID: 11101356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitumor and antiviral properties of 5-alkyl-2'-deoxyuridines, 3',5'-cyclic monophosphates, and neutral cyclic triesters.
    Bères J; Bentrude WG; Balzarini J; De Clercq E; Otvös L
    J Med Chem; 1986 Apr; 29(4):494-9. PubMed ID: 3959027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 6-substituted-5-fluorouridine ProTides.
    Slusarczyk M; Ferla S; Brancale A; McGuigan C
    Bioorg Med Chem; 2018 Feb; 26(3):551-565. PubMed ID: 29277307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.